10 Adverse events 5% in SUSTAIN 5 8,10 AEs occurring in 5% of participants treated with Ozempic in SUSTAIN 5 Incidence of severe hypoglycemia was 1.5% across all placebo-controlled trials 1 Incidence of severe hypoglycemia or blood glucose-confirmed hypoglycemia (% of patients) was 8,10 : 8.3% with Ozempic 0.5 mg + basal insulin MET 10.7% with Ozempic 1 mg + basal insulin MET 5.3% with placebo + basal insulin MET Patients receiving Ozempic in combination with an insulin secretagogue (eg, sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia 1 ADA=American Diabetes Association
Siroosbakht, S., Rezakhaniha, S
Carr, E
You would have to take 0.5mg or 1mg, neither of which is what was prescribed
It's a hormone made in the gut that helps regulate blood sugar and appetite, particularly after eating
Patients should be counseled that evidence for low-dose regimens specifically for inflammation is limited, and alternative evidence-based anti-inflammatory strategies (lifestyle modification, statins, specific anti-inflammatory medications for diagnosed conditions) should be prioritized